Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Abstract Tirzepatide is a new drug targeting glucagon-like peptide 1(GLP1) and gastric inhibitory polypeptide (GIP) receptors
GLP-1RAs exert pleiotropic effects, including anti-inflammatory, anti-atherosclerotic, and endothelial-protective properties
Studies have found it to be non-sensitizing, non-phototoxic, and non-photoallergenic
(Primary corporate readout for the TRIUMPH-4 efficacy and safety summary
Signal transduction and targeted therapy
US$ 28.22
US$ 20.46
US$ 21.31
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 29.09
